These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31212704)

  • 1. Lysophosphatidic Acid Signaling in Diabetic Nephropathy.
    Lee JH; Kim D; Oh YS; Jun HS
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy.
    Lee GH; Cheon J; Kim D; Jun HS
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
    Li HY; Oh YS; Choi JW; Jung JY; Jun HS
    Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells.
    Kim D; Nam GY; Seo E; Jun HS
    J Biomed Sci; 2022 May; 29(1):31. PubMed ID: 35538534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model.
    Zhang MZ; Wang X; Yang H; Fogo AB; Murphy BJ; Kaltenbach R; Cheng P; Zinker B; Harris RC
    J Am Soc Nephrol; 2017 Nov; 28(11):3300-3311. PubMed ID: 28739650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Levels of Renal Lysophosphatidic Acid in Rodent Models with Renal Disease.
    Hirata T; Smith SV; Takahashi T; Miyata N; Roman RJ
    J Pharmacol Exp Ther; 2021 Feb; 376(2):240-249. PubMed ID: 33277348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
    Yang F; Chen GX
    World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary lysophopholipids are increased in diabetic patients with nephropathy.
    Saulnier-Blache JS; Feigerlova E; Halimi JM; Gourdy P; Roussel R; Guerci B; Dupuy A; Bertrand-Michel J; Bascands JL; Hadjadj S; Schanstra JP
    J Diabetes Complications; 2017 Jul; 31(7):1103-1108. PubMed ID: 28506691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of lysophosphatidic acid and its receptors in the kidney.
    Park F; Miller DD
    Physiol Genomics; 2017 Nov; 49(11):659-666. PubMed ID: 28939644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.
    Meduri B; Pujar GV; Durai Ananda Kumar T; Akshatha HS; Sethu AK; Singh M; Kanagarla A; Mathew B
    Eur J Med Chem; 2021 Oct; 222():113574. PubMed ID: 34126459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.
    Willier S; Butt E; Grunewald TG
    Biol Cell; 2013 Aug; 105(8):317-33. PubMed ID: 23611148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1/MAPK/KLF5 signaling.
    Kim D; Li HY; Lee JH; Oh YS; Jun HS
    Exp Mol Med; 2019 Feb; 51(2):1-10. PubMed ID: 30770784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
    Sokolov E; Eheim AL; Ahrens WA; Walling TL; Swet JH; McMillan MT; Simo KA; Thompson KJ; Sindram D; McKillop IH
    J Surg Res; 2013 Mar; 180(1):104-13. PubMed ID: 23182454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases.
    Jiang S; Yang H; Li M
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Lysophosphatidic Acid Receptors in Ovarian Cancer: A Minireview.
    Cui R; Bai H; Cao G; Zhang Z
    Crit Rev Eukaryot Gene Expr; 2020; 30(3):265-272. PubMed ID: 32749113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
    Balijepalli P; Sitton CC; Meier KE
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.
    Zhao Y; Natarajan V
    Cell Signal; 2009 Mar; 21(3):367-77. PubMed ID: 18996473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
    Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
    Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid (LPA) signaling in vertebrate reproduction.
    Ye X; Chun J
    Trends Endocrinol Metab; 2010 Jan; 21(1):17-24. PubMed ID: 19836970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.